Il-2 muteins and uses thereof
AssigneePandion Operation, Inc.
InventorsNathan HIGGINSON-SCOTT, Joanne L. VINEY, Jyothsna VISWESWARAIAH, Erik Robert SAMPSON, Kevin Lewis OTIPOBY
Life of this patent
Estimating the term…
Abstract
The present application provides for IL-2 muteins, compositions comprising the same, and methods of using the same.
Claims21
1-63. (canceled)
A method of increasing T regulatory cell proliferation in a subject, the method comprising administering to the subject a pharmaceutical composition comprising a peptide comprising an amino acid sequence of SEQ. ID. NO:
- 27.
A method of activating T regulatory cells in a subject, the method comprising administering to the subject a pharmaceutical composition comprising a peptide comprising an amino acid sequence of SEQ. ID. NO:
- 27.
Dependencies are inferred from the claim text.